Farms.com Home   News

Ag Outlook: Brazil is looking at largest soybean crop ever

Global economics and the impact for agriculture were a key focus during the Annual Ag Outlook yesterday.

Brad Magnusson, CEO of Magnusson Consulting Group covered a lot of ground from oil and gas prices to the war in Ukraine, and more. 

A key area of interest is the potential impact of an increase in U.S. acres.

He says the USDA is expecting to see an increase in soybeans, winter wheat and spring wheat, with corn acres jumping 1.9 million acres.

"Now what impact is that having? Well, first of all, we're starting to see fertilizers slide in the form of nitrogen. I think a lot of us including ourselves, bought expensive nitrogen in and around $1100 in the fall.  It's down to around about $910 yesterday ( Monday )."

He notes the biggest problem that a lot of fertilizer companies are having right now is delivery issues adding that he anticipates fertilizer prices will come back up as the demand increases.

Another key area to watch is Brazil, where they have a very, very large bean crop that could see production hit 154 or 159.1 million tonnes making it their largest soybean crop ever.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.